Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-039896
Filing Date
2012-05-24
Accepted
2012-05-24 21:31:38
Documents
1
Period of Report
2012-05-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4006
  Complete submission text file 0001104659-12-039896.txt   5532
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Banham John Michael Middlecott (Reporting) CIK: 0001357635 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 12869141